Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Imunon
NRG Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
AGO Study Group
Hoffmann-La Roche
Advenchen Laboratories, LLC
Seoul National University Hospital
pharmaand GmbH
Hoffmann-La Roche
AGO Study Group
GOG Foundation
Canadian Cancer Trials Group
Seoul National University Hospital
National Cancer Institute (NCI)
Genentech, Inc.
Amgen
Alliance for Clinical Trials in Oncology
MEI Pharma, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Medical Research Council
Eli Lilly and Company